533 related articles for article (PubMed ID: 9023264)
1. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
Florijn WJ; Tarazi FI; Creese I
J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
Tarazi FI; Florijn WJ; Creese I
Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
[TBL] [Abstract][Full Text] [Related]
3. Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats.
See RE; Toga AW; Ellison G
J Neural Transm Gen Sect; 1990; 82(2):93-109. PubMed ID: 1977417
[TBL] [Abstract][Full Text] [Related]
4. Differential in vivo inhibition of [3H]nemonapride binding by atypical antipsychotics in rat striatum, olfactory lobes, and frontal cortex.
Assié MB; Consul-Denjean N; Koek W; Newman-Tancredi A
Pharmacology; 2005 Oct; 75(2):63-8. PubMed ID: 16020947
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL
Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485
[TBL] [Abstract][Full Text] [Related]
6. Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics.
Tarazi FI; Florijn WJ; Creese I
Psychopharmacology (Berl); 1996 Dec; 128(4):371-9. PubMed ID: 8986008
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
8. Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatum.
Dean B; Hussain T; Scarr E; Pavey G; Copolov DL
Life Sci; 2001 Aug; 69(11):1257-68. PubMed ID: 11521750
[TBL] [Abstract][Full Text] [Related]
9. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
Malmberg A; Jerning E; Mohell N
Eur J Pharmacol; 1996 May; 303(1-2):123-8. PubMed ID: 8804920
[TBL] [Abstract][Full Text] [Related]
10. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
Janowsky A; Neve KA; Kinzie JM; Taylor B; de Paulis T; Belknap JK
J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
[TBL] [Abstract][Full Text] [Related]
11. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
Terai M; Hidaka K; Nakamura Y
Eur J Pharmacol; 1989 Dec; 173(2-3):177-82. PubMed ID: 2576228
[TBL] [Abstract][Full Text] [Related]
12. Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains.
Tang SW; Helmeste DM; Fang H; Li M; Vu R; Bunney W; Potkin S; Jones EG
Brain Res; 1997 Aug; 765(1):7-12. PubMed ID: 9310388
[TBL] [Abstract][Full Text] [Related]
13. Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390.
Lidow MS; Goldman-Rakic PS; Gallager DW; Rakic P
Neuroscience; 1991; 40(3):657-71. PubMed ID: 2062437
[TBL] [Abstract][Full Text] [Related]
14. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
[TBL] [Abstract][Full Text] [Related]
15. Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand.
Seeman P; Van Tol HH
Eur J Pharmacol; 1995 Oct; 291(2):59-66. PubMed ID: 8566176
[TBL] [Abstract][Full Text] [Related]
16. Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats.
Ossowska K; Pietraszek M; Wardas J; Nowak G; Wolfarth S
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):280-7. PubMed ID: 10344526
[TBL] [Abstract][Full Text] [Related]
17. Is clozapine selective for the dopamine D4 receptor?
Durcan MJ; Rigdon GC; Norman MH; Morgan PF
Life Sci; 1995; 57(18):PL275-83. PubMed ID: 7475902
[TBL] [Abstract][Full Text] [Related]
18. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
Jenner P; Rupniak NM; Marsden CD
Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
[TBL] [Abstract][Full Text] [Related]
19. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
Hall H; Wedel I
Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):368-73. PubMed ID: 2943136
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
Robertson GS; Fibiger HC
Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
